返回 Agenda
S21 : Recommendations for Plain Language Summary to Promote Mutual Understanding
Session Chair(s)
Kotone Matsuyama, RPh
Professor, Department of Health Policy and Management
Nippon Medical School, Japan
Speaker(s)
Nobutaka Yagi
Nippon Boehringer Ingelheim Co., Ltd. / YORIAILab Inc., Japan
Senior Patient Engagement Medical Advisor / Representing Director
Hiroyuki Wadahama
Center for iPS Cell Research and Application, Kyoto University, Japan
International Public Communications Office, Specially Appointed Associate Profes
Hisayoshi Hashimoto
Astrazeneca K.K., Japan
R&D Late Development Oncology, Medical Science Director
Aki Kitabayashi
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Inspector, Office of Non-clinical and Clinical Compliance